A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy Subjects
Clinical trial NCT03058419 · COMPLETED
Trial details
- NCT number
- NCT03058419
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-14
- Primary completion
- 2017-05-15
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.